The internationalisation of innovation to China: The case of AstraZeneca PLC. / Zhao, Shasha; Papanastassiou, Marina; Tan, Hui.

Academy of International Business 42nd UKI Chapter Conference Proceedings. Manchester Metropolitan University Business School. 2015.

Research output: Chapter in Book/Report/Conference proceedingChapter

Published

Standard

The internationalisation of innovation to China: The case of AstraZeneca PLC. / Zhao, Shasha; Papanastassiou, Marina; Tan, Hui.

Academy of International Business 42nd UKI Chapter Conference Proceedings. Manchester Metropolitan University Business School. 2015.

Research output: Chapter in Book/Report/Conference proceedingChapter

Harvard

Zhao, S, Papanastassiou, M & Tan, H 2015, The internationalisation of innovation to China: The case of AstraZeneca PLC. in Academy of International Business 42nd UKI Chapter Conference Proceedings. Manchester Metropolitan University Business School.

APA

Zhao, S., Papanastassiou, M., & Tan, H. (2015). The internationalisation of innovation to China: The case of AstraZeneca PLC. In Academy of International Business 42nd UKI Chapter Conference Proceedings. Manchester Metropolitan University Business School

Vancouver

Zhao S, Papanastassiou M, Tan H. The internationalisation of innovation to China: The case of AstraZeneca PLC. In Academy of International Business 42nd UKI Chapter Conference Proceedings. Manchester Metropolitan University Business School. 2015

Author

Zhao, Shasha ; Papanastassiou, Marina ; Tan, Hui. / The internationalisation of innovation to China: The case of AstraZeneca PLC. Academy of International Business 42nd UKI Chapter Conference Proceedings. Manchester Metropolitan University Business School. 2015.

BibTeX

@inbook{1a76ad40f73c47b9ae486e47352ed783,
title = "The internationalisation of innovation to China: The case of AstraZeneca PLC.",
abstract = "The internationalisation of firms is increasingly concerned with locating innovation activities in the most appropriate locations, particularly for more strategic research and development projects. This article attempts to explore this area by taking a slightly different perspective – the internationalisation of innovations by advance-economy firms in less-advanced economies – which is increasingly prominent in international business development. This article describes the history of international expansion of AstraZeneca from 1990s to year 2014, which demonstrates the development of the company with its unique approach to international business operations, and in particular its innovation. In order to explain such a progress, considerations are given to a number of theoretical frameworks in terms of their explanatory power.",
author = "Shasha Zhao and Marina Papanastassiou and Hui Tan",
year = "2015",
month = jun,
day = "23",
language = "English",
booktitle = "Academy of International Business 42nd UKI Chapter Conference Proceedings. Manchester Metropolitan University Business School",

}

RIS

TY - CHAP

T1 - The internationalisation of innovation to China: The case of AstraZeneca PLC.

AU - Zhao, Shasha

AU - Papanastassiou, Marina

AU - Tan, Hui

PY - 2015/6/23

Y1 - 2015/6/23

N2 - The internationalisation of firms is increasingly concerned with locating innovation activities in the most appropriate locations, particularly for more strategic research and development projects. This article attempts to explore this area by taking a slightly different perspective – the internationalisation of innovations by advance-economy firms in less-advanced economies – which is increasingly prominent in international business development. This article describes the history of international expansion of AstraZeneca from 1990s to year 2014, which demonstrates the development of the company with its unique approach to international business operations, and in particular its innovation. In order to explain such a progress, considerations are given to a number of theoretical frameworks in terms of their explanatory power.

AB - The internationalisation of firms is increasingly concerned with locating innovation activities in the most appropriate locations, particularly for more strategic research and development projects. This article attempts to explore this area by taking a slightly different perspective – the internationalisation of innovations by advance-economy firms in less-advanced economies – which is increasingly prominent in international business development. This article describes the history of international expansion of AstraZeneca from 1990s to year 2014, which demonstrates the development of the company with its unique approach to international business operations, and in particular its innovation. In order to explain such a progress, considerations are given to a number of theoretical frameworks in terms of their explanatory power.

M3 - Chapter

BT - Academy of International Business 42nd UKI Chapter Conference Proceedings. Manchester Metropolitan University Business School

ER -